Abstract:Mehdi Abedi, 1 Samira Sadat Abolmaali, 1, 2 Mozhgan Abedanzadeh, 1 Fatemeh Farjadian, 2 Soliman Mohammadi Samani, 2, 3 Ali Mohammad Tamaddon 1, 2 1 Department of Pharmaceutical Nanotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran; 2 Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran; 3 Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran Correspondence: Ali Mohammad Tamaddon Department of Pharmaceutical Nanotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran Tel +98 71 32424126 Email amtamadon@gmail.com Introduction: As widely used chemotherapeutic agents, platinum compounds have several therapeutic challenges, such as drug resistance and adverse effects. Theranostic systems, macromolecular or colloidal therapeutics with companion diagnostics, not only address controlled drug delivery but also enable real-time monitoring of tumor sites. Methods: Synthesis of magnetic mesoporous silica nanoparticles (MMSNs) was performed for dual magnetic resonance imaging and drug delivery. MMSN surfaces were modified by imidazoline groups (MMSN-Imi) for cisplatin (Cis-Pt) conjugation via free N-termini to achieve well-controlled drug-release kinetics. Cis-Pt adsorption isotherms and drug-release profile at pH 5 and 7.4 were investigated using inductively coupled plasma atomic emission spectroscopy. Results: MMSN-Imi showed a specific surface area of 517.6 m 2 g − 1 , mean pore diameter of 3.26 nm, and saturated magnetization of 53.63 emu/g. A relatively high r 2 /r 1 relaxivity value was obtained for MMSN-Imi. The nanoparticles provided high Cis-Pt loading with acceptable loading capacity (∼ 30% w:w). Sustained release of Cis-Pt under acidic conditions led to specific inhibitory effects on the growth of human epithelial ovarian carcinoma cells, determined using MTT assays. Dual acridine orange–propidium iodide staining was investigated, confirming induction of apoptosis and necrotic cell death. Conclusion: MMSN-Imi exhibited potential for applications in cancer chemotherapy and combined imaging. Keywords: magnetic properties, cisplatin, SiO 2 , theranostic, MRI, drug delivery

Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy

Design of magnetic nanoplatforms for simultaneous molecular imaging and cisplatin delivery for breast cancer cells theranostics

Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent

Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer

SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer

Using chitosan-coated magnetite nanoparticles as a drug carrier for opioid delivery against breast cancer

Synthesis of Surface Modified Fe3O4 Super Paramagnetic Nanoparticles for Ultra Sound Examination and Magnetic Resonance Imaging for Cancer Treatment.

Influence of SPION Surface Coating on Magnetic Properties and Theranostic Profile

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Core–Shell Imidazoline–Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound

Surface modification of super paramagnetic iron oxide nanoparticles via milk casein for potential use in biomedical areas

Polymeric Reactor for the Synthesis of Superparamagnetic-Thermal Treatment of Breast Cancer

Utilization of Chemically Synthesized Super Paramagnetic Iron Oxide Nanoparticles in Drug Delivery, Imaging and Heavy Metal Removal

Synthesis and characterization of amine-functionalized Fe3O4/Mesoporous Silica Nanoparticles (MSNs) as potential nanocarriers in drug delivery systems

A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy

A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles

Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells

Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21 expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe<sub>3</sub>O<sub>4</sub> nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy

Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation